Irish drugmaker Jazz Pharmaceuticals (JAZZ) broke out as it extended its St. Patrick’s week rally. The stock broke out past a 183.94 buy point of a second-stage base Wednesday in above-average volume and is more than 1% above the entry. Jazz recovered from a failed breakout past 177.11 in late February.